Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Research & Development (2016)

MedWellAI (MWAI) has disclosed Research & Development for 2 consecutive years, with $738.0 as the latest value for Q4 2016.

  • Quarterly Research & Development fell 63.48% to $738.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $15574.0 through Mar 2017, down 47.37% year-over-year, with the annual reading at $21636.0 for FY2017, 82.0% down from the prior year.
  • Research & Development for Q4 2016 was $738.0 at MedWellAI, down from $894.0 in the prior quarter.
  • The five-year high for Research & Development was $13942.0 in Q1 2016, with the low at $738.0 in Q4 2016.